Indian markets continue to navigate a challenging macro environment marked by currency volatility, elevated crude oil prices, and cautious foreign investor sentiment. In this backdrop, market veteran Ambareesh Baliga believes pharmaceutical stocks remain one of the safer sectors for investors seeking stability.
Speaking to ET Now, Baliga said the rupee is likely to remain range-bound unless crude oil prices cool significantly and foreign institutional investors return meaningfully to Indian equities.
